Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study by Fassnacht, Martin, MD, Berruti, Alfredo, MD, Baudin, Eric, MD, Demeure, Michael J, MD, Gilbert, Jill, MD, Haak, Harm, MD, Kroiss, Matthias, MD, Quinn, David I, FRACP, Hesseltine, Elizabeth, MSN, Ronchi, Cristina L, MD, Terzolo, Massimo, MD, Choueiri, Toni K, MD, Poondru, Srinivasu, PhD, Fleege, Tanya, MS, Rorig, Ramona, Chen, Jihong, PhD, Stephens, Andrew W, MD, Worden, Francis, MD, Hammer, Gary D, Prof

Get full text